Skip to main content

Teladoc Health Inc

For the period ended Jun 30, 2024. Filed Aug 1, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 1, 2024

TDOC$8.98+2.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Exhibit Index

Exhibit

Index

Incorporated by Reference
ExhibitNumberExhibit DescriptionFormFile No.ExhibitFilingDateFiledHerewith
3.1Seventh Amended and Restated Certificate of Incorporation of Teladoc Health, Inc.8-K001-374773.16/2/22
3.2Seventh Amended and Restated Bylaws of Teladoc Health, Inc.10-K001-374773.22/23/24
10.1Offer Letter, dated as of June 5, 2024, by and between Teladoc Health, Inc. and Charles Divita.8-K001-3747710.16/10/24
10.2Employment Agreement, dated as of June 10, 2024, by and between Teladoc Health, Inc. and Charles Divita.8-K001-3747710.26/10/24
10.3Chief Executive Officer Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan.*
10.4 · Form of Chief Executive Officer Performance Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan. · *
10.5Letter Agreement, dated as of April 1, 2024, by and between Teladoc Health, Inc. and Mala Murthy.10-Q001-3747710.14/26/24
10.6Amendment No. 2 to Executive Severance Agreement, dated as of June 6, 2024, by and between Teladoc Health, Inc. and Mala Murthy.8-K001-3747710.36/10/24
10.7Retention Bonus Agreement, dated as of April 26, 2024, by and between Teladoc Health, Inc. and Adam Vandervoort.10-Q001-3747710.34/26/24
10.8Amendment No. 2 to Executive Severance Agreement, dated as of April 26, 2024, by and between Teladoc Health, Inc. and Adam Vandervoort.10-Q001-3747710.44/26/24
10.9Release and Separation Agreement, dated as of April 11, 2024, by and between Teladoc Health, Inc. and Jason Gorevic.10-Q001-3747710.24/26/24
10.10First Amendment to Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan.8-K001-3747710.46/10/24
31.1Chief Executive Officer—Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2Chief Financial Officer—Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1Chief Executive Officer—Certification pursuant to Rule13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2Chief Financial Officer—Certification pursuant to Rule13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within theInline XBRL document.*
101.SCHXBRL Taxonomy Extension Schema Document.*
101.CALXBRL Taxonomy Calculation Linkbase Document.*
101.DEFXBRL Definition Linkbase Document.*
101.LABXBRL Taxonomy Label Linkbase Document.*
101.PREXBRL Taxonomy Presentation Linkbase Document.*
104Cover Page Interactive Data File – The Cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

*Filed herewith.

**Furnished herewith.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.